Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A44410 | 28692197 | J Gastroenterol Hepatol | The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups. | 2018 | Details |
| A44411 | 28691883 | Immunopharmacol Immunotoxicol | Correction to: Bahabadi M, et al., Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease. | 2017 | Details |
| A44412 | 28691683 | Lancet Gastroenterol Hepatol | Surrogate endpoints for clinical trials in non-alcoholic steatohepatitis - Author's reply. | 2017 | Details |
| A44413 | 28691682 | Lancet Gastroenterol Hepatol | Surrogate endpoints for clinical trials in non-alcoholic steatohepatitis. | 2017 | Details |
| A44414 | 28691681 | Lancet Gastroenterol Hepatol | Is it time to change NAFLD and NASH nomenclature? | 2017 | Details |
| A44415 | 28690178 | J Hepatol | Fructose, uric acid, and zonal differences in NASH. | 2017 | Details |
| A44416 | 28690177 | J Hepatol | Reply to: "Fructose, uric acid and zonal differences in NASH". | 2017 | Details |
| A44417 | 28688146 | Hepatology | Exercise and NAFLD: Is it worth the effort? | 2017 | Details |
| A44418 | 28685102 | Neural Plast | Autism-Like Behaviours and Memory Deficits Result from a Western Diet in Mice. | 2017 | Details |
| A44419 | 28677287 | Aliment Pharmacol Ther | Editorial: new insights into the relationship between the intestine and non-alcoholic fatty liver-is "fatty gut" involved in disease progression? | 2017 | Details |
| A44420 | 28677122 | FEBS Lett | From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions. | 2017 | Details |
| A44421 | 28676901 | Dig Dis Sci | Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? | 2017 | Details |
| A44422 | 28676712 | Nat Rev Gastroenterol Hepatol | NAFLD: Increased familial risk of fibrosis in NAFLD. | 2017 | Details |
| A44423 | 28671424 | Am Fam Physician | Nonalcoholic Fatty Liver Disease: Identifying Patients at Risk of Inflammation or Fibrosis. | 2017 | Details |
| A44424 | 28670712 | J Gastroenterol Hepatol | Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment. | 2018 | Details |
| A44425 | 28668407 | Eur J Radiol | Current and cutting-edge interventions for the treatment of obese patients. | 2017 | Details |
| A44426 | 30191057 | Hepat Oncol | Nonalcoholic fatty liver disease and hepatocellular carcinoma. | 2017 | Details |
| A44427 | 28657965 | AIDS | Fatty liver disease in HIV: common, underappreciated, and understudied. | 2017 | Details |
| A44428 | 28656280 | Mol Med Rep | Role of glycoprotein 78 and cidec in hepatic steatosis. | 2017 | Details |
| A44429 | 28655878 | Nat Rev Gastroenterol Hepatol | NAFLD: Thermoneutral housing of mice improves modelling of NAFLD. | 2017 | Details |
| A44430 | 28655407 | Gastroenterol Hepatol | Turner syndrome as a cause of liver cirrhosis. | 2017 | Details |
| A44431 | 30992977 | Clin Liver Dis (Hoboken) | Putting it all together: Noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in adults and children. | 2017 | Details |
| A44432 | 28653754 | Hepatology | Adipose-derived exosomal MicroRNAs orchestrate gene regulation in the liver: Is this the missing link in nonalcoholic fatty liver disease? | 2017 | Details |
| A44433 | 28647352 | Gastroenterology | How to Approach a Patient With Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A44434 | 28646550 | Hepatology | Healthy controls in nonalcoholic fatty liver disease management: A biomedical research perspective. | 2017 | Details |
| A44435 | 28642206 | Clin Gastroenterol Hepatol | Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally-Derived Anthropometric Measures. | 2017 | Details |
| A44436 | 28635910 | Ter Arkh | [Involvement of the hepatobiliary system and pancreas in obesity]. | 2019 | Details |
| A44437 | 28631945 | Curr Med Res Opin | Vildagliptin: any effect on non-alcoholic fatty liver disease and serum uric acid? Re: Shelbaya S, Rakha S. Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt - results from the GUARD study. Curr Med Res Opin 2017;33:797-801. | 2017 | Details |
| A44438 | 28628040 | J Clin Invest | Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity. | 2017 | Details |
| A44439 | 28624648 | Clin Gastroenterol Hepatol | Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice. | 2017 | Details |
| A44440 | 28622190 | Exerc Sport Sci Rev | Are Exercise Benefits in Nonalcoholic Fatty Liver Disease Due to Increased Autophagy? | 2017 | Details |
| A44441 | 28621080 | Aliment Pharmacol Ther | Letter: the efficacy of oltipraz in patients with non-alcoholic fatty liver disease has not been confirmed-authors' reply. | 2017 | Details |
| A44442 | 28621072 | Aliment Pharmacol Ther | Letter: the efficacy of oltipraz in patients with non-alcoholic fatty liver disease has not been confirmed. | 2017 | Details |
| A44443 | 28619256 | J Hepatol | Pre-natal and post-natal environment monitoring to prevent non-alcoholic fatty liver disease development. | 2017 | Details |
| A44444 | 28618839 | Crit Rev Biochem Mol Biol | Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology. | 2017 | Details |
| A44445 | 28611479 | Nat Rev Gastroenterol Hepatol | NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD. | 2017 | Details |
| A44446 | 28601844 | Gut | The role of hepatokines in NAFLD-related extrahepatic diseases: culprit or accomplice? | 2017 | Details |
| A44447 | 28601674 | J Hepatol | The relationship between age and fat infiltration in liver and muscle. | 2017 | Details |
| A44448 | 28598214 | Biomark Med | Exosomal miRNAs as biomarkers in the diagnosis of liver disease. | 2017 | Details |
| A44449 | 28596428 | Eur Respir J | Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm? | 2017 | Details |
| A44450 | 28596414 | Am J Physiol Gastrointest Liver Physiol | Letter to the editor: Treating nonalcoholic fatty liver disease with statins. Are all statins equal? | 2017 | Details |
| A44451 | 28591634 | Cell Metab | A Cell-Autonomous Mammalian 12 hr Clock Coordinates Metabolic and Stress Rhythms. | 2017 | Details |
| A44452 | 28590260 | Curr Opin Clin Nutr Metab Care | Ghrelin and autophagy. | 2017 | Details |
| A44453 | 28589576 | Aliment Pharmacol Ther | Editorial: non-alcoholic fatty liver disease-a pandemic in need of novel treatments and endpoints. | 2017 | Details |
| A44454 | 31305674 | Medicine (Baltimore) | Erratum: Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia: Erratum. | 2017 | Details |
| A44455 | 28578313 | Evid Based Med | High-intensity exercise offers no additional benefit to moderate-intensity exercise in reducing liver fat in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A44456 | 28577062 | Med Mol Morphol | Hepatic progenitor cell expansion in early-stage nonalcoholic steatohepatitis: evidence from immunohistochemistry and immunoelectron microscopy of matrix metalloproteinase-1. | 2017 | Details |
| A44457 | 28571684 | Nutrition | Mediterranean diet to prevent/treat nonalcoholic fatty liver disease in children: A promising approach. | 2017 | Details |
| A44458 | 31089501 | J Obes Metab Syndr | The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A44459 | 28556755 | Pediatr Exerc Sci | Effects of Exercise Training Alone on Depot-Specific Body Fat Stores in Youth: Review of Recent Literature. | 2017 | Details |
| A44460 | 28552526 | Biochem Biophys Res Commun | Liver receptor homolog-1 regulates mouse superoxide dismutase 2. | 2017 | Details |
| A44461 | 28549675 | Clin Gastroenterol Hepatol | Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis. | 2017 | Details |
| A44462 | 28548281 | J Intern Med | Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. | 2017 | Details |
| A44463 | 28539844 | Gastroenterol Hepatol (N Y) | Bariatric Surgery and Liver Transplantation. | 2017 | Details |
| A44464 | 28539357 | J Lipid Res | Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns. | 2017 | Details |
| A44465 | 28539218 | Bioorg Med Chem Lett | Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists. | 2017 | Details |
| A44466 | 28538268 | Eur J Gastroenterol Hepatol | Etiological factors of chronic hepatitis in Italy: a 2014 national survey. | 2017 | Details |
| A44467 | 28534956 | Mol Med Rep | Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity. | 2017 | Details |
| A44468 | 28529811 | Case Reports Hepatol | Glycogenic Hepatopathy: Resolution with Minimal Glucose Control. | 2017 | Details |
| A44469 | 28521334 | Nutr Rev | Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. | 2017 | Details |
| A44470 | 28514463 | JAMA Dermatol | Pediatric Psoriasis Comorbidity Screening Guidelines. | 2017 | Details |
| A44471 | 28514295 | Medicine (Baltimore) | Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy. | 2017 | Details |
| A44472 | 28513633 | Nat Rev Gastroenterol Hepatol | NAFLD: A gut microbiome signature for advanced fibrosis diagnosis in NAFLD. | 2017 | Details |
| A44473 | 28513098 | J Diabetes | Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control. | 2017 | Details |
| A44474 | 28511575 | Prog Transplant | Liver Transplantation for Non-Alcoholic Steatohepatitis Related Cirrhosis. | 2017 | Details |
| A44475 | 28506368 | Gastroenterol Clin North Am | Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Liver Pathology. | 2017 | Details |
| A44476 | 28506114 | J Am Coll Nutr | The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients. | 2017 | Details |
| A44477 | 28503563 | Hepatobiliary Surg Nutr | Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease. | 2017 | Details |
| A44478 | 28503562 | Hepatobiliary Surg Nutr | The natural history of nonalcoholic fatty liver disease: mortality rates and liver enzymes. | 2017 | Details |
| A44479 | 28502788 | Clin Gastroenterol Hepatol | Reply. | 2017 | Details |
| A44480 | 28502381 | Atherosclerosis | Linking lysosomal acid lipase insufficiency to the development of cryptogenic cirrhosis. | 2017 | Details |
| A44481 | 28495427 | J Hepatol | O-GlcNAcylation: Undesired tripmate but an opportunity for treatment in NAFLD-HCC. | 2017 | Details |
| A44482 | 28489415 | Am J Respir Cell Mol Biol | Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis. | 2017 | Details |
| A44483 | 28487614 | World J Gastroenterol | Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma. | 2017 | Details |
| A44484 | 28484194 | Nihon Shokakibyo Gakkai Zasshi | Metabolic syndrome and NAFLD/NASH. | 2019 | Details |
| A44485 | 28484192 | Nihon Shokakibyo Gakkai Zasshi | The diagnosis, biomarker and imaging of NASH. | 2019 | Details |
| A44486 | 28484191 | Nihon Shokakibyo Gakkai Zasshi | Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A44487 | 28484190 | Nihon Shokakibyo Gakkai Zasshi | Recent research trends on the pathogenesis of nonalcoholic fatty liver disease. | 2019 | Details |
| A44488 | 28483681 | J Hepatol | The IRGM rs10065172 variant increases the risk for steatosis but not for liver damage progression in Italian obese children. | 2017 | Details |
| A44489 | 28483561 | J Sci Med Sport | Cardiorespiratory fitness, waist circumference and liver enzyme levels in European adolescents: The HELENA cross-sectional study. | 2017 | Details |
| A44490 | 28483066 | J Pediatr | The Highs and Lows of Fetal Programming for Fatty Liver Disease. | 2017 | Details |
| A44491 | 28480982 | Hepatology | Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study. | 2017 | Details |
| A44492 | 28473603 | J Lipid Res | Increased hepatic mitochondrial FA oxidation reduces plasma and liver TG levels and is associated with regulation of UCPs and APOC-III in rats. | 2017 | Details |
| A44493 | 28471888 | Transplantation | Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation: More Questions Than Answers? | 2017 | Details |
| A44494 | 28469226 | Am J Gastroenterol | Vitamin D's Role in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A44495 | 28469220 | Am J Gastroenterol | Reply to Kim et al. | 2017 | Details |
| A44496 | 28468762 | Gut | Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus-authors' response. | 2017 | Details |
| A44497 | 28465155 | J Pharm Sci | Effect of Liver Disease on Hepatic Transporter Expression and Function. | 2017 | Details |
| A44498 | 28464597 | Zhonghua Yu Fang Yi Xue Za Zhi | [Study about the risk factors of non-alcoholic fatty liver disease among people aged over 60 years old in Suzhou]. | 2017 | Details |
| A44499 | 28463859 | Curr Opin Lipidol | Adiponectin, lipids and atherosclerosis. | 2017 | Details |
| A44500 | 28459766 | Curr Opin Lipidol | Mode of action of berberine on lipid metabolism: a new-old phytochemical with clinical applications? | 2017 | Details |
| A44501 | 28459036 | Indian J Endocrinol Metab | Consensus Statement on Dose Modifications of Antidiabetic Agents in Patients with Hepatic Impairment. | 2020 | Details |
| A44502 | 28457103 | Isr Med Assoc J | Association between non-alcoholic fatty liver disease and hospitalized patients with community-acquired pneumonia. | 2017 | Details |
| A44503 | 33379824 | J Appl Lab Med | The Enhanced Liver Fibrosis (ELF) Panel: Analyte Stability Under Common Sample Storage Conditions Used in Clinical Practice. | 2017 | Details |
| A44504 | 28452211 | Gut Liver | Erratum: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. | 2017 | Details |
| A44505 | 28448873 | Biomed Pharmacother | Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cells. | 2017 | Details |
| A44506 | 28447751 | Mol Med Rep | Deep sea water improves hypercholesterolemia and hepatic lipid accumulation through the regulation of hepatic lipid metabolic gene expression. | 2017 | Details |
| A44507 | 28445235 | J Clin Gastroenterol | Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota: A US Population-based Study. | 2017 | Details |
| A44508 | 28434491 | Lancet Diabetes Endocrinol | Semaglutide, lipid-lowering drugs, and NAFLD - Author's reply. | 2017 | Details |
| A44509 | 28434490 | Lancet Diabetes Endocrinol | Semaglutide, lipid-lowering drugs, and NAFLD. | 2017 | Details |